急性淋巴细胞白血病(acute lymphoblastic leukemia,ALL) 急性髓细胞白血病(acute myeloblasticleukemia,AML)或称为急性非淋巴细胞白血病(ANLL) MICM分型方案:1999 年,世界卫生组织( WHO ) 在欧- 美淋巴组织肿瘤分类方案修订版(REAL)的基础上,将血液肿瘤相关疾病的临床特点与形态学(morphology)、免疫学(immunology)、细胞...
急性淋巴细胞白血病(Acutelymphoblasticleukemia,ALL),是最常见的儿童恶性肿瘤.统计数据显示,中国儿童ALL的发病率为2.17/10万,是成人的3倍,其中1～4岁发病率最高.对于... 李雁铭 被引量: 0发表: 2023年 儿童肿瘤防治500问 刘秋玲主编的这本《儿童肿瘤防治500问》介绍了常见的儿童恶性肿瘤的疾病概况,对于基层医务...
Mammalian Notch was first identified in 1991 in a translocation that brought the Notch1 gene under the transcriptional control of the T-cell receptor β locus in a T-cell acute lymphoblastic leukemia (T-ALL) cell line.2 This early observation of Notch translocation in T-cell leukemia led many...
急性淋巴细胞白血病(acute lymphoblastic leukemia,ALL) 急性髓细胞白血病(acute myeloblasticleukemia,AML)或称为急性非淋巴细胞白血病(ANLL) MICM分型方案:1999 年,世界卫生组织( WHO ) 在欧- 美淋巴组织肿瘤分类方案修订版(REAL)的基础上,将血液肿瘤相关疾病的临床特点与形态学(morphology)、免疫学(immunology)、细胞...
In the past few years, CAR T cells targeting Cluster of Differentiation 19 (CD19) have achieved impressive outcomes in the treatment of patients with relapsed or refractory (R/R) acute lymphoblastic leukemia (ALL) [7–9]. Although CD19 CAR T cell treatment of R/R B-NHL has been less ...